Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Mar 15;134(6):609–610.

Hypoprothrombinemic hemorrhage due to cholestyramine therapy.

A M Shojania, D Grewar
PMCID: PMC1490907  PMID: 3948073

Full text

PDF
609

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acuña R., González Ceron M. Hipoprotrombinemia y sindrome hemorragiparo asociado a tratamiento con colestiramina. Rev Med Chil. 1977 Jan;105(1):27–28. [PubMed] [Google Scholar]
  2. Casdorph H. R. Safe uses of cholestyramine. Ann Intern Med. 1970 May;72(5):759–759. doi: 10.7326/0003-4819-72-5-759. [DOI] [PubMed] [Google Scholar]
  3. Davies V. A., Rothberg A. D., Argent A. C., Atkinson P. M., Staub H., Pienaar N. L. Precursor prothrombin status in patients receiving anticonvulsant drugs. Lancet. 1985 Jan 19;1(8421):126–128. doi: 10.1016/s0140-6736(85)91901-4. [DOI] [PubMed] [Google Scholar]
  4. Gross L., Brotman M. Hypoprothrombinemia and hemorrhage associated with cholestyramine therapy. Ann Intern Med. 1970 Jan;72(1):95–96. doi: 10.7326/0003-4819-72-1-95. [DOI] [PubMed] [Google Scholar]
  5. Hofmann A. F., Poley J. R. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med. 1969 Aug 21;281(8):397–402. doi: 10.1056/NEJM196908212810801. [DOI] [PubMed] [Google Scholar]
  6. Mountain K. R., Hirsh J., Gallus A. S. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet. 1970 Feb 7;1(7641):265–268. doi: 10.1016/s0140-6736(70)90636-7. [DOI] [PubMed] [Google Scholar]
  7. Srinivasan G., Seeler R. A., Tiruvury A., Pildes R. S. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol. 1982 Feb;59(2):250–252. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES